A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan
- 15 January 1991
Abstract
In Japan, hepatocellular carcinoma (HCC) is one of the most prevalent cancers, with a reported fatality rate showing a consistent and significant increase in the last decade. At most, only 25% of HCC cases are positive for the hepatitis B surface antigen (HBsAg). To investigate a potential role for hepatitis C virus (HCV) in the development of HCC, sera from 105 HBsAg-negative HCC patients were collected from five districts of Japan and assayed for antibody to HCV antigen (HCVAb). A large number of these patients (76.2%) were found to be positive for the HCVAb in comparison with the reported prevalence in sera from blood donors (1.1%). A history of blood transfusion was found in 39.6% of the cases positive for HCVAb, which was significantly different to the lower rate (4.7%) observed in HCC patients who were both positive for HBsAg and negative for HCVAb (P less than 0.001).Keywords
This publication has 12 references indexed in Scilit:
- Serodiagnosis of Recent Hepatitis B Infection by IgM Class Anti-HBcHepatology, 2007
- Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.Proceedings of the National Academy of Sciences, 1990
- Prevalence of Anti‐HCV Antibody in Blood Donors in the Tokyo AreaVox Sanguinis, 1990
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- Survey and follow-up study of primary liver cancer in Japan. Report 8.Kanzo, 1988
- Primary liver cancer in Japan. Sixth reportCancer, 1987
- Survey and follow-up study of primary liver cancer in Japan. Report 7.Kanzo, 1986
- ANTIBODY TO HEPATITIS-B CORE ANTIGEN IN PATIENTS WITH PRIMARY HEPATIC CARCINOMAThe Lancet, 1975
- Hemagglutination Assay for Antigen and Antibody Associated with Viral HepatitisScience, 1970